Abstract
The experience in organizing the creation of innovative immunobiological drugs and vaccines is discussed—from laboratory developments to industrial technologies and the registration of finished forms of effective and safe drugs that are in demand in the domestic and foreign markets. The principles of their action rely on the latest global achievements in the field of immunobiology and vaccinology.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
